INTERNATIONAL PATENT: PROQR THERAPEUTICS II B.V., ELI LILLY AND COMPANY FILES APPLICATION FOR "ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF HURLER SYNDROME"

GENEVA, July 30 -- PROQR THERAPEUTICS II B.V. (Zernikedreef 92333 CK Leiden), ELI LILLY AND COMPANY (Lilly Corporate CenterP.O. Box 6288Indianapolis, Indiana 46206) filed a patent application (PCT/US2025/012183) for "ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF HURLER SYNDROME" on Jan 17, 2025. With publication no. WO/2025/155911, the details related to the patent application was published on Jul 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VAN SINT FIET, Lenka (c/o ProQR Therapeutics II B.V.Zernikedreef 92333 CK Leiden), KEMMEL, Cherie Paige (c/o ProQR Therapeutics II B.V.Zerniked...